Monopar Therapeutics (MNPR) Return on Capital Employed (QoQ) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Monopar Therapeutics | 466.82 Mn | 466.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 600.00 |
| Sep 30, 2023 | -1,285.00 |
| Jun 30, 2023 | -849.00 |
| Mar 31, 2023 | -1,158.00 |
| Dec 31, 2022 | -2,303.00 |
| Sep 30, 2022 | -728.00 |
| Jun 30, 2022 | -1,491.00 |
| Mar 31, 2022 | -741.00 |
| Mar 31, 2021 | 453.00 |
| Dec 31, 2020 | -304.00 |
| Sep 30, 2020 | 62.00 |
| Jun 30, 2020 | -540.00 |
| Mar 31, 2020 | 1,880.00 |
| Dec 31, 2019 | 3,185.00 |
| Sep 30, 2019 | -1,125.00 |
| Jun 30, 2019 | -1,279.00 |
| Mar 31, 2019 | -1,479.00 |
| Dec 31, 2018 | -605.00 |
| Sep 30, 2018 | 16,516.00 |
| Jun 30, 2018 | -1,779.00 |